The PMC website is updating on 03/14/2022. Try out this update now on PMC Labs or Learn more.

Logo of croatmedjFree full text at www.cmj.hrAboutSubscribeSubmitInfo for AuthorsFree full text at www.cmj.hr
Croat Med J. 2008 Jun; 49(3): 441–443.
PMCID: PMC2443630
PMID: 18581625

How to Say “Thanks” in Phoenician

It is difficult to find a physician on this planet who in his/her office does not have a gift from his or her patient or a pharmaceutical company representative – a note-book, calendar, or at least a pencil with the logo of a friendly pharmaceutical company. Certain companies are much more generous and pay lengthy stays in exclusive hotels, on all-inclusive basis. Over the last few years, industries connected with health (pharmaceutical, bio-technological, and producers of equipment) only in the United States (USA) have invested US $16 billion into the marketing targeting physicians, US $2 billion of this sum being spent just on meals and contacts with physicians. Physicians are constantly faced by 90 thousand representatives of pharmaceutical companies and millions of ads in professional journals. These representatives pay to physicians to help them develop educational materials; they also “domesticate” physicians and students of medicine supplying them with free text-books, stethoscopes, and free meals. The Americans have a saying: “There ain’t no such a thing as free lunch” – the dividing line between marketing and non-ethical behavior of pharmaceutical companies is indeed very thin and unclear (1).

Persuasive education

Pharmaceutical companies try to incite in a physician a feeling of obligation toward the company and its representative so that physicians could prescribe as many of their pharmaceuticals as possible. However, it sometimes happens that a physician’s obligation toward the company is contradictory to their obligation toward the patients. There are studies proving that after so many free fancy dinners and stays at expensive hotels, physicians prescribe many more products of the generous company, although these products are in no way better than the competing products – having, as a rule, no idea that they are victims of a subtle and elegant form of manipulation.

Not only in the USA, but in the most of other developed countries, nine tenths of medical education are organized or sponsored by industries connected with health, which is called “persuasive education.” During such education, a pharmaceutical company – of course, there are no formal obligations! – persuades the physicians that their products are superior to the almost identical, but cheaper competing products.

Let us suppose that such a physician daily prescribes only five boxes of a medication that is just €5 more expensive than another pharmaceutical (in ophthalmology, for instance, the difference in the price of very similar eye drops does not exceed the ratio of 5:1, which makes about €14; while the difference in the price of psychiatric pharmaceutical olanzapine amounts to €27 per package), this makes €550 a month, ie, about €6500 a year (2). If the state would more closely monitor such practices and pay to each physician €3000 for two weeks of education in some fine hotel at the French or Spanish coast, it would still save €3500 per each physician.

No vaccine so far

Public opinion perceives corruption as an individual phenomenon and discovery of each corrupt physician is breaking news. However, no part of the health system has been vaccinated against corruption, since bribe and corruption are immanent to the system itself, not to the individuals.

Governmental surveillance and regulatory bodies (ministries, parliaments, special commissions) are very susceptible to corruption. Moreover, the presence of regulation broadens the possibilities for corruptive activities. For example, pharmaceutical companies may influence law-making and regulatory commissions and boards to make sure that their pharmaceuticals get covered either by insurance or paid by patients themselves, or they may influence official recommendations and clinical algorithms for the use of medicines or diagnostic procedures to speed up or slow down the entry of a pharmaceutical to the market or allow that it enters the market without adequate testing (3).

This is why, several years ago, the antirheumatic rofecoxib (4) had to be noisily withdrawn from the market – it had been found that it significantly amplified the risk of cardiovascular diseases. In March 2007, tegaserod, a drug against constipation and irritable bowel syndrome, was withdrawn because of cardiovascular ischemic events (5).

Clean hands and a finger in the pie

Although insurance companies are often affected by corruption activities undertaken by other participants in the health system, these companies, even national insurance companies, may be corrupt themselves. They may, for example, simply direct the investments to their political allies. And this is, as is usual with corruption, very difficult to prove.

Transitional countries expect that private insurance companies would contribute to a better and more efficient health system. But even private insurers may be involved in corruption, for example, when they, dealing with state-subsidised programs, issue false receipts. Furthermore, they may reject to pay insurance compensations, although they are obliged by the law to do it or they may bribe the state supervisors of the insurance to ignore illegal acts (6).

Croatian hospitals are given more than a half of the health budget, which was more than €1.3 billion in 2008 (7). The costs of hospitals include not only medical care, but also huge investments in buildings and expensive technology, and these are exactly the areas where the largest corruption takes place.

The sums used in Croatia to build and equip hospitals are by no means insignificant. This year, the major part of the new hospital complex in the Croatian capital Zagreb was finished. So far, the investment amounted to about €150 billion. Knowing that corruption is immanent to all health systems in the world, it would be very surprising if nobody had a finger in the pie.

In a Phoenician way

Pharmaceutical and equipment industry is an area hugely riddled with corruption. Pharmaceutical companies and providers sometimes try hard to persuade the procurement officers of the hospitals to buy their pharmaceuticals or equipment, even if they are too expensive or unnecessary (8,9).

Although, theoretically, the all expensive equipment should be purchased by tender, precise specifications could be made to exclude all providers except one. The provider would then express its gratitude; ever since the Phoenicians had invented money, the need for the word “thank you” has considerably diminished.

Routine maintenance of the hospital buildings and equipment makes corruption possible in many other ways as well. For instance, hospital maintenance service declares itself (!) incompetent to fix or rebuild something and seeks another company to perform these tasks. The same goes for the procurement of pharmaceuticals or equipment – technical staff in such a case may of course expect some expression of gratitude from the company to which they re-direct their own job, in a Phoenician way, or through expensive business presents like laptops, cellular phones (combined with cost of all calls), car leases, or paid trips (10).

Can free lunches be healthy?

Although the public is most sensitive to bribes with money and “gifts,” one of the most common forms of corruption is “stealing” the working hours. The hospital personnel has fixed wages and there is practically no supervision on the quality of their work, so they are not stimulated by the hospital to work more or better. Therefore, it is quite usual to come to work late and leave earlier. In many countries, those who are employed in state institutions, but have a private practice as well, often leave earlier from their workplace to be able to work privately.

Finally, what is corruption? According to the definition of the non-profit organization Transparency International, corruption is “an abuse of public authority.” Corruption in the health system is defined as “an abuse of entrusted authority.” In other words, corruption includes all “dishonest actions of physicians, hospitals, and other health care professionals, who are generally afforded high social and professional status and are expected to exercise professional medical judgement unbiased by private financial interests” (4).

Transparency International estimates that a loss caused yearly by corruption in developed countries amounts to 10% (6). Interestingly, Croatian health-budget chronically lacks about 10% of its money.

Of course, receiving a pencil, a medical book, or some other small gift from pharmaceutical company is not the same as participating in a systematic corruption or double-dealing on a large scale. But we physicians must be aware that health system is far from functioning in an economic or moral vacuum (11). So, there’s no such a thing as a free lunch in the health system.

References

1. Petersen M. Our daily meds. New York (NY): Farrar, Straus and Giroux; 2008. [Google Scholar]
2. Croatian Institute for Health Insurance. Basic list of drugs. Available from: http://www.hzzo-net.hr/lista_lijekova/Osnovna_lista_lijekova_20080101.doc Accessed: June 01, 2008.
3. Lewis M. Governance and corruption in public health care systems. Center for Global Development Working Paper Number 78. 2006. Available from: http://www.cgdev.org/content/publications/detail/5967 Accessed: June 01, 2008.
4. U.S. Food and Drug Administration. Vioxx (rofecoxib) questions and answers. Available from: http://www.fda.gov/cder/drug/infopage/vioxx/vioxxQA.htm Accessed: June 01, 2008.
5. U.S. Food and Drug Administration. Questions and answers about the voluntary discontinuation of Zelnorm’s (tegaserod maleate) treatment investigational new drug (IND). Available from: http://www.fda.gov/CDER/DRUG/infopage/zelnorm/QA_2008.htm Accessed: June 01, 2008.
6. Transparency International. Global Corruption Report 2006. Part one: Corruption and health. The causes of corruption in the health sector: a focus on health care systems. Available from: http://www.transparency.org/content/download/4816/28503/file/Part%201_1_causes%20of%20corruption.pdf Accessed: June 01, 2008.
7. National budget of Republic of Croatia for year 2008. General part. Available from: http://www.mfin.hr/download.php?id=1354 Accessed: June 01, 2008.
8. Transparency International. Global Corruption Report 2006. Part one: Corruption and health. Corruption in the pharmaceutical sector. Available from: http://www.transparency.org/content/download/4819/28512/file/Part%201_5_corruption%20in%20pharma%20sector.pdf Accessed: June 01, 2008.
9. U4 Anti-Corruption Resource Centre. Fraud in hospitals. Available from: http://www.cmi.no/publications/file/?3028=fraud-in-hospitals Accessed: June 01, 2008.
10. U4 Anti-Corruption Resource Centre. Corruption in the health sector. Available from: http://www.u4.no/document/u4-issue/u4_issue1_2006_health.pdf Accessed: June 01, 2008.
11. Stossel TP. Regulating academic-industrial research relationships–solving problems or stifling progress? N Engl J Med. 2005;353:1060–5. doi: 10.1056/NEJMsb051758. [PubMed] [CrossRef] [Google Scholar]

Articles from Croatian Medical Journal are provided here courtesy of Medicinska Naklada